Service utilisation by rural residents with mental health problems.

Centre for Rural Mental Health, Monash University, School of Psychiatry, Psychology and Psychological Medicine, Bendigo Health Care Group, Bendigo, Vic., Australia.
Australasian Psychiatry (Impact Factor: 0.56). 06/2007; 15(3):185-90. DOI: 10.1080/10398560601123724
Source: PubMed

ABSTRACT To examine the level and type of service utilisation by rural residents for mental health problems, and to explore the influence of level of need, sociodemographic factors and town size on such service use.
This was a cross-sectional, community-based study. Subjects were recruited from three locales in rural north-west Victoria: a large regional centre, towns of 5,000-20,000 population and towns of <5,000 population. Three hundred and ninety-one individuals (54% females) participated. A logistic regression analysis was used to investigate which factors (i.e. need, sociodemographic and town size) predicted lifetime help-seeking for emotional or mental problems from formal health providers in the study sample.
Factors that predicted having ever sought help from a formal health provider for emotional or mental health problems were: a lifetime and/or current psychiatric disorder, being female, being separated, divorced or widowed, and living in medium sized towns (population 5,000-20,000).
While traditionally known predictors of help-seeking, i.e need and gender, were associated with help seeking in this study, help seeking for mental health problems was also more common amongst individuals living in medium sized rural towns than those living in a large regional city. Possible explanations include availability, accessibility and organisation of services, and individual and/or community attitudes towards help seeking.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There are two principal types of stigma in mental illness, ie, "public stigma" and "self-stigma". Public stigma is the perception held by others that the mentally ill individual is socially undesirable. Stigmatized persons may internalize perceived prejudices and develop negative feelings about themselves. The result of this process is "self-stigma". Stigma has emerged as an important barrier to the treatment of depression and other mental illnesses. Gender and race are related to stigma. Among depressed patients, males and African-Americans have higher levels of self-stigma than females and Caucasians. Perceived stigma and self-stigma affect willingness to seek help in both genders and races. African-Americans demonstrate a less positive attitude towards mental health treatments than Caucasians. Religious beliefs play a role in their coping with mental illness. Certain prejudicial beliefs about mental illness are shared globally. Structural modeling indicates that conformity to dominant masculine gender norms ("boys don't cry") leads to self-stigmatization in depressed men who feel that they should be able to cope with their illness without professional help. These findings suggest that targeting men's feelings about their depression and other mental health problems could be a more successful approach to change help-seeking attitudes than trying to change those attitudes directly. Further, the inhibitory effect of traditional masculine gender norms on help-seeking can be overcome if depressed men feel that a genuine connection leading to mutual understanding has been established with a health care professional.
    Neuropsychiatric Disease and Treatment 07/2014; 10:1399-1405. DOI:10.2147/NDT.S54081 · 2.15 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: Especially older adults underutilize professional mental health services. However, little is known about the factors associated with older adults' attitudes towards seeking mental health services (ATSMHS). We therefore investigated a wide range of contextual (e.g. physical access, residence) and personal (e.g. perceived social support, life satisfaction, openness to experience) predictors of ATSMHS in a sample of older community-dwelling adults in Germany. We predicted that representations of old age as well as perceptions of (younger) psychotherapists would be uniquely important for determining ATSMHS. Method: A diverse sample of N = 156 older adults (Mage = 71.5 years, SD = 6.4, range: 60-92) completed questionnaire measures. We used hierarchical linear regression analyses to identify predictors of ATSMHS. Results: In the final saturated model, female gender, urban residence, personal and vicarious experience with psychotherapy, and higher perceived social support were each associated with more positive ATSMHS. In addition, more positive representations of old age and less negative perceptions of (younger) psychotherapists explained unique variance in ATSMHS over and above the other predictors. The overall model was significant and explained 49% of the variance in ATSMHS. Conclusion: Our findings can be used to inform interventions to improve older adults' ATSMHS. Interventions that seek to improve older adults' representations of their own aging as well as of psychotherapists may be useful for reducing the treatment gap.
    Aging and Mental Health 06/2014; DOI:10.1080/13607863.2014.920300 · 1.78 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To examine clinician-assisted computerized psychological treatment for depression and alcohol/other drug use comorbidity in rural and urban communities. Methods: Participants in an Australian randomized controlled clinical trial who completed the 3-month post-baseline assessment were examined (n = 163), including those from remote/outer regional (n = 16, 10%) and inner regional (n = 37, 23%) areas and major cities (n = 110, 67%). Participants were using alcohol and/or cannabis at hazardous levels in the month prior to baseline and concurrently reported at least moderate levels of depression. Following provision of the first treatment session (conducted face-to-face for all conditions), participants were randomized to: (1) nine further face-to-face sessions of combination cognitive behavioral therapy and motivational interviewing; (2) nine sessions of combination cognitive behavioral therapy and motivational interviewing delivered via computer, with brief clinician assistance; or (3) nine sessions of supportive counseling. Blind, independent follow-up occurred at 3 months post-baseline. Changes in depression, alcohol, and cannabis use at 3 months post-baseline were the outcomes of interest, with rurality, treatment allocation, and treatment preference fulfilment as independent variables. Self-reported helpfulness and experience of treatment was also explored. Results: Participants completing the 3-month post-baseline assessment (n = 163) were significantly older than those who did not (n = 111) and attended significantly more treatment sessions. The outcomes of interest, including helpfulness of treatment, were not significantly associated with rurality. Of the 92 participants indicating a treatment preference prior to randomization, 13 (14%) nominated a preference for computer-delivered treatment. However, treatment preference did not affect retention, therapeutic alliance, or the benefits reported by urban and rural participants in the trial receiving computerized treatment. Computerized treatment was associated with significantly greater reductions in alcohol use relative to face-to-face cognitive behavioral therapy/motivational interviewing (d = 0.621) and supportive counseling (d = 0.904). Conclusions: Computer-delivered cognitive behavioral therapy and motivational interviewing (with clinical assistance) is an efficacious treatment for depressive and addictive disorders, with similar levels of acceptability and benefit in rural and urban participants. Computerized psychological treatment might be an acceptable treatment for underserviced populations, with real potential to bridge service gaps and to overcome isolation and perceived stigma among isolated communities. This clinical trial is registered with the Australian New Zealand Clinical Trials Registry as trial #ACTRN12610000274077 (
    Journal of Dual Diagnosis 11/2012; 8(4):262-276. DOI:10.1080/15504263.2012.723315 · 0.80 Impact Factor


Available from
May 27, 2014